Organisation paid for research Program year 2025 Source: CMS Open Payments

Believe Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$131,536

5 payments

Through program year 2025, Believe Clinical Trials is reported as receiving $131,536 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$48,600	2
2024	Research	$65,143	2
2023	Research	$17,793	1

Breakdown

Who paid Research payments · program years 2023–2025

E.R. Squibb & Sons, L.L.C. $48,600 2 payments
Eli Lilly and Company $42,660 2 payments
Amgen Inc. $40,276 1 payment

Studies the money was for Research payments · program years 2023–2025

P1b Uncontrolled GoutA A $40,276 1 payment
Taltz Psa Observational Study $24,867 1 payment
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2) $24,300 1 payment
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1) $24,300 1 payment
Taltz Psa Observational Study $17,793 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.